El-Gowily, A.H.; Loutfy, S.A.; Ali, E.M.M.; Mohamed, T.M.; Mansour, M.A.
RETRACTED: Tioconazole and Chloroquine Act Synergistically to Combat Doxorubicin-Induced Toxicity via Inactivation of PI3K/AKT/mTOR Signaling Mediated ROS-Dependent Apoptosis and Autophagic Flux Inhibition in MCF-7 Breast Cancer Cells. Pharmaceuticals 2021, 14, 254.
https://doi.org/10.3390/ph14030254
AMA Style
El-Gowily AH, Loutfy SA, Ali EMM, Mohamed TM, Mansour MA.
RETRACTED: Tioconazole and Chloroquine Act Synergistically to Combat Doxorubicin-Induced Toxicity via Inactivation of PI3K/AKT/mTOR Signaling Mediated ROS-Dependent Apoptosis and Autophagic Flux Inhibition in MCF-7 Breast Cancer Cells. Pharmaceuticals. 2021; 14(3):254.
https://doi.org/10.3390/ph14030254
Chicago/Turabian Style
El-Gowily, Afnan H., Samah A. Loutfy, Ehab M. M. Ali, Tarek M. Mohamed, and Mohammed A. Mansour.
2021. "RETRACTED: Tioconazole and Chloroquine Act Synergistically to Combat Doxorubicin-Induced Toxicity via Inactivation of PI3K/AKT/mTOR Signaling Mediated ROS-Dependent Apoptosis and Autophagic Flux Inhibition in MCF-7 Breast Cancer Cells" Pharmaceuticals 14, no. 3: 254.
https://doi.org/10.3390/ph14030254
APA Style
El-Gowily, A. H., Loutfy, S. A., Ali, E. M. M., Mohamed, T. M., & Mansour, M. A.
(2021). RETRACTED: Tioconazole and Chloroquine Act Synergistically to Combat Doxorubicin-Induced Toxicity via Inactivation of PI3K/AKT/mTOR Signaling Mediated ROS-Dependent Apoptosis and Autophagic Flux Inhibition in MCF-7 Breast Cancer Cells. Pharmaceuticals, 14(3), 254.
https://doi.org/10.3390/ph14030254